Exact Sciences Schedules Fourth Quarter 2023 Earnings Call
Exact Sciences Corp. (Nasdaq: EXAS) plans to release its fourth quarter 2023 financial results on February 21, 2024, followed by a webcast and conference call to discuss financial results and business progress. The webcast and call will be open to all interested parties.
02/01/2024 - 06:00 AM
MADISON, Wis. --(BUSINESS WIRE)--
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its fourth quarter 2023 financial results after the close of the U.S. financial markets on February 21, 2024. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.
Fourth quarter 2023 webcast & conference call details
Date:
Wednesday, February 21, 2024
Time:
5 p.m. ET
Webcast:
The live webcast can be accessed at www.exactsciences.com
Telephone:
Domestic callers, dial 888-330-2384
International callers, dial +1 240-789-2701
Access code for both domestic and international callers: 4437608
A replay of the webcast will be available at www.exactsciences.com . The webcast, conference call, and replay are open to all interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com , follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240201496564/en/
Nathan Harrill
Exact Sciences Corp.
investorrelations@exactsciences.com
608-535-8659
Source: Exact Sciences Corp.
When will Exact Sciences Corp. release its fourth quarter 2023 financial results?
Exact Sciences Corp. plans to release its fourth quarter 2023 financial results after the close of the U.S. financial markets on February 21, 2024.
What is the ticker symbol for Exact Sciences Corp.?
The ticker symbol for Exact Sciences Corp. is EXAS.
How can I access the live webcast for the fourth quarter 2023 financial results?
The live webcast can be accessed at www.exactsciences.com.
What time will the webcast and conference call to discuss financial results and business progress take place?
The webcast and conference call will take place at 5 p.m. ET on Wednesday, February 21, 2024.
How can I access the replay of the webcast?
The replay of the webcast will be available at www.exactsciences.com.
EXAS Rankings
#234 Ranked by Stock Gains
EXAS Stock Data
Industry
Diagnostic Imaging Centers
Sector
Health Care and Social Assistance
Tags
Health Technology, Biotechnology
Country
US
City
Madison
About EXAS
exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com